Effect of serum amyloid A on selected in vitro functions of isolated human neutrophils

Journal of Laboratory and Clinical Medicine

Volumn 132, Issue 5, 1998, Pages 414-420

  Gatt, Moshe E ^b   Urieli Shoval, Simcha ^b   Preciado Patt, Liana ^b   Fridkin, Mati ^b   Calco, Sima ^b   Azar, Yehudit ^b   Matzner, Yaacov ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032213207     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(98)90112-3     Document Type: Article

References (31)

1. Borregaard N. The human neutrophil. Function and dysfunction. Eur J Haematol 1988;41:401-13.
2. Matzner Y. Acquired neutrophil dysfunction and diseases with an inflammatory component. Semin Hematol 1997;34:291-302.
3. Eriksen N, Meek RL, Benditt EP. The SAA lipoprotein family. Acute phase proteins: molecular biology, biochemistry and clinical applications. In: Mackiewicz A, Kushner I, Baumann H, editors. Boca Raton: CRC Press; 1993. p. 93-106.
4. Kushner I. The phenomenon of the acute phase response. Ann NY Acad Sci 1982;389:39-48.
5. Hoffman JS, Benditt EP. Changes in high density lipoprotein content following endotoxin administration in the mouse: formation of serum amyloid protein-rich subfraction. J Biol Chem 1982;257:10510-7.
6. Meek RL, Urieli-Shoval S, Benditt EP. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc Natl Acad Sci USA 1994;91:3186-90.
7. Yamada T, Kakihara T, Kamishima T, Fukuda T, Kawai T. Both acute phase and constitutive serum amyloid A are present in atherosclerotic lesions. Pathol Int 1996;46:797-800.
8. Urieli-Shoval S, Meek RL, Hanson RH, Eriksen N, Benditt EP. Human serum amyloid A genes are expressed in monocyte/macrophage cell lines. Am J Pathol 1994;145:650-60.
9. Aldo-Benson MA, Benson MD. SAA supression of immune response in vitro: evidence for an effect on T cell-macrophage interaction. J Immunol 1982;128:2390-2.
10. 2 production from bovine aortic endothelial cells by serum amyloid A and its N-terminal tetradecapeptide. Biomed Pept Proteins Nucleic Acids 1997;2:101-6.
11. Shainkin-Kestenbaum R, Berlyne G, Zimlichman S, Sorin HR, Nyska M, Danon A. Acute phase protein serum amyloid A inhibits IL-1 and TNF induced fever and hypothalamic PGE2 in mice. Scand J Immun 1991;34:179-83.
12. Preciado-Patt L, Cahalon L, Hershkovitz R, Lider O, Pras M, Fridkin M. Serum amyloid A complexed with extracellular matrix induces the secretion of tumor necrosis factor α by human T-lymphocytes. Letters in Peptide Science. In press.
13. Zimlichman S, Danon A, Nathan I, Mozes G, Shainkin-Kestenbaum R. Serum amyloid A, an acute phase protein, inhibits platelet activation. J Lab Clin Med 1990;116:180-6.
14. Baumberger C, Ulevitch RI, Dayer JM. Modulation of endotoxic activity of lipopolysaccharides by high density lipoprotein. Pathobiology 1991;59:378-83.
15. 2- microglobulin-like proteins. Science 1989;243:655-7.
16. Linke RP, Bock V, Valet G, Rothe G. Inhibition of the oxidative burst response of N-formyl peptide stimulated neutrophils by serum amyloid A protein. Biochem Biophys Res Commun 1991;176:1100-5.
17. Preciado-Patt L, Pras M, Fridkin M. Binding of human serum amyloid A (hSAA) and its high-density lipoprotein 3 complex (hSAA-HDL3) to human neutrophils. Possible implication to the function of a protein of an unknown physiological role. Int J Pept Protein Res 1996;48:503-13.
18. Preciado-Patt L, Hershkovitz R, Fridkin M, Lider O. Serum amyloid A binds specific extracellular matrix glycoproteins and induces the adhesion of resting CD4+ T cells. J immunol 1996;156:1189-95.
19. Badolato R, Wang JM, Murphy WJ, Lloyd AR, Michiel DF, Bausserman LL, et al. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med 1994;180:203-9.
20. Badolato R, Johnston JA, Wang JM, McVicar D, Xu LL, Oppenheim JJ. Serum amyloid A induces calcium mobilization and chemotaxis of human monocytes by activating a pertussis toxin-sensitive signaling pathway. J Immunol 1995;155;4004-10.
21. Steinkasserer A, Weiss EH, Schwaeble W, Linke RP. Heterogeneity of human serum amyloid A protein. Five different variants from one individual demonstrated by cDNA sequence analysis. Biochem J 1990;268:187-93.
22. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968;97(supp):77-89.
23. Zigmund SH, Hirsch JG. Leukocyte locomotion and chemotaxis: new methods for evaluation and demonstration of cell-derived chemotactic factor. J Exp Med 1973;137:387-410.
24. Matzner Y, Brzezinski A. A C5a inhibitor in peritoneal fluid. J Lab Clin Med 1984;103:227-35.
25. Ayesh SK, Azar Y, Barghouti II, Ruedi JM, Babior BM, Matzner Y. Purification and characterisation of C5a inactivating enzyme from human peritoneal fluid. Blood 1995;85:3503-9.
26. Wroblewski F, LaDue JS. Lactic dehydrogenase activity in blood. Proc Soc Exp Biol Med 1955;90:210-3.
27. Matzner Y, Brass LM, McMurrich BJ, Peters WA, Andre-Schwartz J, Babior BM. Expression of chronic granulomatous disease-like defect by fluoride exhausted neutrophils. Blood 1982;60:822-6.
28. Matzner Y, Vlodavsky I, Michaeli R, Eldor A. Selective inhibition of neutrophil activation by the subendothelial extracelluler matrix: possible role in protection of the vessel wall during diapedesis. Exp Cell Res 1990;189:233-40.
29. Preciado-Patt L, Levartowsky D, Pras M, Hershkovitz R, Lider O, Fridkin M. Inhibition of cell adhesion to glycoproteins of the extracellular matrix by peptides corresponding to serum amyloid A. Eur J Biochem 1994;223:35-42.
30. Preciado-Patt L, Fridkin M. Inhibition by serum amyloid A and its related peptides of cell adhesion to extracellular matrix components. In: Schneider CH, editor. Peptides in immunology. New York: John Wiley and Sons; 1996. p. 235-8.
31. Shainkin-Kestenbaum R, Zimlichman S, Lis M, Lidor C, Pomerantz M, Knyszynski A, et al. Effect of serum amyloid A, HDL-apolypoprotein, on endothelial cell proliferation. Implication of an enigmatic protein to atherosclerosis. Biomed Pept Proteins Nucleic Acids 1997;2:79-84.